Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark D Minden

Showing results (41-50 of 308) with videos related to

Pageof 31
Sort By:
Leukemia & Lymphoma|January 7, 2016
Investigating the synergistic mechanism between ibrutinib and daunorubicin in acute myeloid leukemia cellsLianne E Rotin, Marcela Gronda, Rose Hurren, et al.
British Journal of Haematology|April 3, 2003
Clinical manifestations associated with the aberrant expression of the soluble granulocyte-macrophage colony-stimulating factor receptor in patients presenting with haematological malignanciesMichael R Trus, Louise Bordeleau, Carin Pihl, et al.
Cell Reports. Medicine|January 14, 2022
Targeted blockade of immune mechanisms inhibit B precursor acute lymphoblastic leukemia cell invasion of the central nervous systemSujeetha A Rajakumar, Ildiko Grandal, Mark D Minden, et al.
Leukemia Research|September 15, 2018
Acute promyelocytic leukemia in the intensive care unit: A retrospective analysisBruno L Ferreyro, Laveena Munshi, Michael E Detsky, et al.
Annals of Transplantation|November 5, 2024
The Long-Acting Glucagon-Like Peptide-2 Analog Apraglutide Enhances Intestinal Protection and Survival After Chemotherapy and Allogeneic Transplantation in MiceMark D Minden, Cindy Audiger, Geneviève Chabot-Roy, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 10, 2009
Health care crisis in GazaAaron D Schimmer, David Malkin, Eldad Zackenhaus, et al.
Cytometry. Part B, Clinical Cytometry|September 16, 2006
Flow cytometric assessment of autologous gammadelta T cells in patients with acute myeloid leukemia: potential effector cells for immunotherapy?Jorg M Aswald, Xing-Hua Wang, Sandra Aswald, et al.
Nature Reviews. Cancer|January 26, 2007
Myelodysplastic syndromes: the complexity of stem-cell diseasesSeth J Corey, Mark D Minden, Dwayne L Barber, et al.
Cancers|October 23, 2021
Enhancing Therapeutic Efficacy of Double Negative T Cells against Acute Myeloid Leukemia Using IdelalisibHyeonjeong Kang, Jong Bok Lee, Ismat Khatri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 27, 2020
Combination of FLT3-ITD Allelic Ratio, NPM1 Mutation, and Immunophenotypic Markers to Modulate Outcome Prediction in Patients with Normal Karyotype Acute Myelogenous Leukemia Undergoing Hematopoietic Stem Cell TransplantationGina Jiang, Jose-Mario Capo-Chichi, Aijun Liu, et al.
Pageof 31

Showing results (41-50 of 308) with videos related to

Sort By:
Pageof 31
Leukemia & Lymphoma|January 7, 2016
Investigating the synergistic mechanism between ibrutinib and daunorubicin in acute myeloid leukemia cellsLianne E Rotin, Marcela Gronda, Rose Hurren, et al.
British Journal of Haematology|April 3, 2003
Clinical manifestations associated with the aberrant expression of the soluble granulocyte-macrophage colony-stimulating factor receptor in patients presenting with haematological malignanciesMichael R Trus, Louise Bordeleau, Carin Pihl, et al.
Cell Reports. Medicine|January 14, 2022
Targeted blockade of immune mechanisms inhibit B precursor acute lymphoblastic leukemia cell invasion of the central nervous systemSujeetha A Rajakumar, Ildiko Grandal, Mark D Minden, et al.
Leukemia Research|September 15, 2018
Acute promyelocytic leukemia in the intensive care unit: A retrospective analysisBruno L Ferreyro, Laveena Munshi, Michael E Detsky, et al.
Annals of Transplantation|November 5, 2024
The Long-Acting Glucagon-Like Peptide-2 Analog Apraglutide Enhances Intestinal Protection and Survival After Chemotherapy and Allogeneic Transplantation in MiceMark D Minden, Cindy Audiger, Geneviève Chabot-Roy, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|June 10, 2009
Health care crisis in GazaAaron D Schimmer, David Malkin, Eldad Zackenhaus, et al.
Cytometry. Part B, Clinical Cytometry|September 16, 2006
Flow cytometric assessment of autologous gammadelta T cells in patients with acute myeloid leukemia: potential effector cells for immunotherapy?Jorg M Aswald, Xing-Hua Wang, Sandra Aswald, et al.
Nature Reviews. Cancer|January 26, 2007
Myelodysplastic syndromes: the complexity of stem-cell diseasesSeth J Corey, Mark D Minden, Dwayne L Barber, et al.
Cancers|October 23, 2021
Enhancing Therapeutic Efficacy of Double Negative T Cells against Acute Myeloid Leukemia Using IdelalisibHyeonjeong Kang, Jong Bok Lee, Ismat Khatri, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 27, 2020
Combination of FLT3-ITD Allelic Ratio, NPM1 Mutation, and Immunophenotypic Markers to Modulate Outcome Prediction in Patients with Normal Karyotype Acute Myelogenous Leukemia Undergoing Hematopoietic Stem Cell TransplantationGina Jiang, Jose-Mario Capo-Chichi, Aijun Liu, et al.
Pageof 31